Zimmer Biomet Quarterly Cash Flow Statement
NYSE: ZBHHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zimmer Biomet free cash flow
In the quarter ended Jun 30, 2026, Zimmer Biomet generated $447.8 million of operating cash flow and spent $54.2 million on capital expenditures. That left free cash flow of $393.6 million, a free-cash-flow margin of 18.1% of revenue. Free cash flow was up 20.0% from the prior year's $328.1 million.
Zimmer Biomet returned $297.2 million to shareholders: $46.5 million in dividends and $250.7 million in share repurchases, equal to 76% of free cash flow. Free cash flow covered dividend payments 8.5 times.
Summary generated from market data by MetaCap's automated system. Methodology
Zimmer Biomet cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 199.60M | 238.30M | 137.90M | 231.20M | 153.40M | 182.60M | 240.20M | 249.30M | 243.10M | 172.80M | 419.70M | 162.90M |
| Net Income growth (YoY) | +30.12% | +30.50% | -42.59% | -7.26% | -36.90% | +5.67% | -42.77% | +53.04% | +15.87% | -25.77% | — | -16.12% |
| Depreciation & Amortization | 270.80M | 270.00M | 284.00M | 283.60M | 271.80M | 254.40M | 263.60M | 250.90M | 243.20M | 238.60M | 241.20M | 241.20M |
| Stock-Based Compensation | 24.60M | 24.20M | 24.10M | 25.30M | 21.20M | 19.60M | 21.10M | 24.50M | 26.40M | 29.00M | 25.30M | 15.60M |
| Change in Working Capital | 23.00M | -189.40M | 185.60M | -94.50M | 39.80M | -58.20M | -79.00M | -49.30M | -36.10M | -197.40M | 68.60M | -91.00M |
| Operating Cash Flow | 447.80M | 359.40M | 517.40M | 418.70M | 378.20M | 382.80M | 506.30M | 395.70M | 369.40M | 228.00M | 588.40M | 337.60M |
| Capital Expenditures | -54.20M | -36.30M | -74.80M | -55.00M | -50.10M | -44.60M | -51.50M | -44.50M | -52.70M | -55.10M | -62.80M | -84.30M |
| Investing Cash Flow | -190.80M | -159.00M | -322.00M | -163.30M | -1.38B | -106.00M | -291.20M | -154.90M | -247.00M | -195.00M | -220.80M | -165.60M |
| Dividends Paid | -46.50M | -46.90M | -47.50M | -47.50M | -47.50M | -47.80M | -48.00M | -49.20M | -49.40M | -49.40M | -50.20M | -50.10M |
| Share Repurchases | -250.70M | -250.10M | -250.00M | 0 | -7.20M | -229.80M | -72.20M | -596.30M | -85.90M | -113.60M | -410.30M | 0 |
| Debt Issued | — | — | 0 | 744.00M | 0 | 1.75B | 736.30M | — | — | — | 499.80M | — |
| Debt Repaid | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | -271.10M | -369.20M | -897.00M | 483.80M | 163.80M | 575.40M | -240.60M | -101.90M | -91.90M | -50.10M | -251.40M | -196.00M |
| Net Change in Cash | -14.20M | -167.70M | -700.80M | 735.80M | -827.70M | 859.10M | -43.60M | 148.90M | 27.10M | -22.70M | 123.60M | -27.60M |
| Free Cash Flow | 393.60M | 323.10M | 442.60M | 363.70M | 328.10M | 338.20M | 454.80M | 351.20M | 316.70M | 172.90M | 525.60M | 253.30M |
This table shows 12 quarterly periods of Zimmer Biomet's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ZBH's reporting calendar. What is a cash flow statement?